Sympathetic-mediated activation versus suppression of the immune system: Consequences for hypertension

Journal of Physiology

Volumn 594, Issue 3, 2016, Pages 527-536

  Case, Adam J ^a   Zimmerman, Matthew C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; NORADRENALIN;

ANTIBODY SPECIFICITY; BLOOD VESSEL; DRUG TARGETING; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION; INFLAMMATION; KIDNEY; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SYMPATHETIC TONE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUPPRESSION; TISSUE INJURY; ADRENERGIC SYSTEM; ANIMAL; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; HUMANS; HYPERTENSION; SYMPATHETIC NERVOUS SYSTEM; T-LYMPHOCYTES;

EID: 84956810415     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP271516     Document Type: Review

References (76)

1. Ahmed AA, Mooar PA, Kleiner M, Torg JS & Miyamoto CT (2011). Hypertensive patients show delayed wound healing following total hip arthroplasty. PloS One 6, e23224.
2. Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD & Wilson CB (1999). Dopamine β-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci USA 96, 2274-2278.
3. Blanc P, Corsi AM, Gabbuti A, Peduzzi C, Meacci F, Olivieri F, Lauretani F, Francesco M & Ferrucci L (2004). Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study. J Am Geriatr Soc 52, 1626-1631.
4. Case AJ & Zimmerman MC (2015). Redox-regulated suppression of splenic T-lymphocyte activation in a model of sympathoexcitation. Hypertension 65, 916-923.
5. Cook PJ, Lip GY, Davies P, Beevers DG, Wise R & Honeybourne D (1998). Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension 31, 589-594.
6. Couzin-Frankel J (2013). Breakthrough of the year 2013. Cancer immunotherapy. Science 342, 1432-1433.
7. Cunnick JE, Lysle DT, Kucinski BJ & Rabin BS (1990). Evidence that shock-induced immune suppression is mediated by adrenal hormones and peripheral β-adrenergic receptors. Pharmacol Biochem Behav 36, 645-651.
8. Deo SH, Jenkins NT, Padilla J, Parrish AR & Fadel PJ (2013). Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via α-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol 305, R1124-R1132.
9. Dobbs CM, Vasquez M, Glaser R & Sheridan JF (1993). Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J Neuroimmunol 48, 151-160.
10. Feldman RD, Hunninghake GW & McArdle WL (1987). Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J Immunol 139, 3355-3359.
11. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA & Livnat S (1987). Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 100, 225-260.
12. Felten SY & Olschowka J (1987). Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp. J Neurosci Res 18, 37-48.
13. Firestein GS (2003). Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
14. Ganta CK, Lu N, Helwig BG, Blecha F, Ganta RR, Zheng L, Ross CR, Musch TI, Fels RJ & Kenney MJ (2005). Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am J Physiol Heart Circ Physiol 289, H1683-H1691.
15. Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D & Granstein RD (2008). Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol 17, 188-196.
16. Grassi G, Mark A & Esler M (2015). The sympathetic nervous system alterations in human hypertension. Circ Res 116, 976-990.
17. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C & Harrison DG (2007). Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204, 2449-2460.
18. Haarala A, Kahonen M, Lehtimaki T, Aittoniemi J, Jylhava J, Hutri-Kahonen N, Taittonen L, Laitinen T, Juonala M, Viikari J, Raitakari OT & Hurme M (2012). Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 167, 309-316.
19. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A & Weyand CM (2011). Inflammation, immunity, and hypertension. Hypertension 57, 132-140.
20. Harrison DG, Marvar PJ & Titze JM (2012). Vascular inflammatory cells in hypertension. Front Physiol 3, 128.
21. Herrera J, Ferrebuz A, MacGregor EG & Rodriguez-Iturbe B (2006). Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 17, S218-S225.
22. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C & Harrison DG (2009). Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296, R208-R216.
23. Hou N, Zhang X, Zhao L, Zhao X, Li Z, Song T & Huang C (2013). A novel chronic stress-induced shift in the Th1 to Th2 response promotes colon cancer growth. Biochem Biophys Res Commun 439, 471-476.
24. Huang JL, Zhang YL, Wang CC, Zhou JR, Ma Q, Wang X, Shen XH & Jiang CL (2012). Enhanced phosphorylation of MAPKs by NE promotes TNF-α production by macrophage through α adrenergic receptor. Inflammation 35, 527-534.
25. + T cells. Brain Behav Immun 24, 1126-1136.
26. Kin NW & Sanders VM (2006). It takes nerve to tell T and B cells what to do. J Leukoc Biol 79, 1093-1104.
27. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J, Bikineyeva AT, Dikalov S, Xiao L, Chen W, Saleh MA, Trott DW, Itani HA, Vinh A, Amarnath V, Amarnath K, Guzik TJ, Bernstein KE, Shen XZ, Shyr Y, Chen SC, Mernaugh RL, Laffer CL, Elijovich F, Davies SS, Moreno H, Madhur MS, Roberts J 2nd & Harrison DG (2014). DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Investig 124, 4642-4656.
28. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN & Hafler DA (2013). Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518-522.
29. + T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53, 487-525.
30. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor GS & Murray G (2000). Medical complications after stroke: a multicenter study. Stroke 31, 1223-1229.
31. Lee SM, Takemoto S & Wallace AW (2015). Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System. Anesthesiology 123, 288-306.
32. 2-Adrenergic mechanisms in experimental arthritis. Proc Natl Acad Sci USA 85, 4553-4556.
33. Li C, Samaranayake NR, Ong KL, Wong HK & Cheung BM (2012). Is human cytomegalovirus infection associated with hypertension? The United States National Health and Nutrition Examination Survey 1999-2002. PloS One 7, e39760.
34. Lip GH, Wise R & Beevers G (1996). Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ 312, 250-251.
35. Lubahn CL, Schaller JA, Bellinger DL, Sweeney S & Lorton D (2004). The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis. Brain Behav Immun 18, 563-571.
36. H2 cells. Brain Behav Immun 25, 408-415.
37. Madden KS, Felten SY, Felten DL, Sundaresan PR & Livnat S (1989). Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behav Immun 3, 72-89.
38. Martelli D, Yao ST, McKinley MJ & McAllen RM (2014). Reflex control of inflammation by sympathetic nerves, not the vagus. J Physiol 592, 1677-1686.
39. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263-270.
40. Mellado M, Martinez-Munoz L, Cascio G, Lucas P, Pablos JL & Rodriguez-Frade JM (2015). T cell migration in rheumatoid arthritis. Front Immunol 6, 384.
41. Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, Greenberg AH & Nance DM (2004). Stress-induced suppression of in vivo splenic cytokine production in the rat by neural and hormonal mechanisms. Brain Behav Immun 18, 262-273.
42. Mracsko E, Liesz A, Karcher S, Zorn M, Bari F & Veltkamp R (2014). Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun 41, 200-209.
43. Nance DM & Sanders VM (2007). Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21, 736-745.
44. Novak TJ & Rothenberg EV (1990). cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 87, 9353-9357.
45. Okuda T & Grollman A (1967). Passive transfer of autoimmune induced hypertension in the rat by lymph node cells. Tex Rep Biol Med 25, 257-264.
46. Olsen F (1970). Type and course of the inflammatory cellular reaction in acute angiotensin-hypertensive vascular disease in rats. Acta Pathol Microbiol Scand A 78, 143-150.
47. Olsen F (1971). Inflammatory cellular reaction in hypertensive vascular disease. Acta Pathol Microbiol Scand Suppl 220, 1-76.
48. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100, 1513-1519.
49. Pitiriga V, Kotsis VT, Alexandrou ME, Petrocheilou-Paschou VD, Kokolakis N, Zakopoulou RN & Zakopoulos NA (2003). Increased prevalence of Chlamydophila pneumoniae but not Epstein-Barr antibodies in essential hypertensives. J Hum Hypertens 17, 21-27.
50. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD & Meisel A (2003). Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198, 725-736.
51. Ramer-Quinn DS, Baker RA & Sanders VM (1997). Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol 159, 4857-4867.
52. + T cells exposed to norepinephrine. Brain Behav Immun 14, 239-255.
53. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J & Johnson RJ (2001). Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59, 2222-2232.
54. Rodriguez-Iturbe B, Quiroz Y, Herrera-Acosta J, Johnson RJ & Pons HA (2002). The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension. J Hypertens Suppl 20, S9-S14.
55. Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR, Kirabo A, Xiao L, Chen W, Itani HA, Michell D, Huan T, Zhang Y, Takaki S, Titze J, Levy D, Harrison DG & Madhur MS (2015). Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 125, 1189-1202.
56. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA & Street NE (1997). Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158, 4200-4210.
57. Seravalle G, Mancia G & Grassi G (2014). Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease. High Blood Press Cardiovasc Prev 21, 89-105.
58. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C & Raizada MK (2010). Brain microglial cytokines in neurogenic hypertension. Hypertension 56, 297-303.
59. Sun Y, Pei W, Wu Y, Jing Z, Zhang J & Wang G (2004). Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res 27, 541-544.
60. Svendsen UG (1973). Increased cellular reaction to damage caused by angiotensin in arterioles of normal recipient rats after transfer of lymphocytes from hypertensive rats. Acta Pathol Microbiol Scand A 81, 241-246.
61. Svendsen UG (1978). The importance of thymus for hypertension and hypertensive vascular disease in rats and mice. Acta Pathol Microbiol Scand Suppl, 1-15.
62. + T cells exposed to norepinephrine. J Immunol 166, 232-240.
63. 1 adrenoceptor. J Neuroimmunol 245, 66-74.
64. Tamir A & Isakov N (1991). Increased intracellular cyclic AMP levels block PKC-mediated T cell activation by inhibition of c-jun transcription. Immunol Lett 27, 95-99.
65. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R & Luft FC (2002). Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2, 3.
66. Vahdat K, Pourbehi MR, Ostovar A, Hadavand F, Bolkheir A, Assadi M, Farrokhnia M & Nabipour I (2013). Association of pathogen burden and hypertension: the Persian Gulf Healthy Heart Study. Am J Hypertens 26, 1140-1147.
67. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG & Guzik TJ (2010). Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122, 2529-2537.
68. Wahle M, Hanefeld G, Brunn S, Straub RH, Wagner U, Krause A, Hantzschel H & Baerwald CG (2006). Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis. Arthritis Res Ther 8, R138.
69. Walter U, Kolbaske S, Patejdl R, Steinhagen V, Abu-Mugheisib M, Grossmann A, Zingler C & Benecke R (2013). Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol 20, 153-159.
70. White FN & Grollman A (1964). Autoimmune factors associated with infarction of the kidney. Nephron 1, 93-102.
71. Wiig H, Schroder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, Boschmann M, Goss J, Bry M, Rakova N, Dahlmann A, Brenner S, Tenstad O, Nurmi H, Mervaala E, Wagner H, Beck FX, Muller DN, Kerjaschki D, Luft FC, Harrison DG, Alitalo K & Titze J (2013). Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 123, 2803-2815.
72. Xiao L, Kirabo A, Wu J, Saleh MA, Zhu L, Wang F, Takahashi T, Loperena R, Foss JD, Mernaugh RL, Chen W, Roberts J 3rd, Osborn JW, Itani HA & Harrison DG (2015). Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Circ Res 117, 547-557.
73. Yan FL & Zhang JH (2014). Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression. Med Sci Monit 20, 2489-2496.
74. Zhang JD, Patel MB, Song YS, Griffiths R, Burchette J, Ruiz P, Sparks MA, Yan M, Howell DN, Gomez JA, Spurney RF, Coffman TM & Crowley SD (2012). A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res 110, 1604-1617.
75. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR & Davisson RL (2002). Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91, 1038-1045.
76. Zimmerman MC, Lazartigues E, Sharma RV & Davisson RL (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95, 210-216.